Active Pharmaceutical Ingredient API News and Research

RSS

KHN’s ‘What the Health?’: The Trump administration’s war on Fauci

Not only does the Trump administration lack a comprehensive plan for addressing the ongoing coronavirus pandemic, it spent much of the past week working to undercut one of the nation’s most trusted scientists, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

16 Jul 2020

KHN’s ‘What the Health?’: ‘Open the schools, close the bars’

How to safely open the nation's schools this fall has become the latest spat in attempting to deal with the COVID-19 pandemic.

9 Jul 2020

Characterizing Polymorphs and Amorphous Form

Dr. Matteo Daldosso and Dr. Sebastian Wegner discuss novel solutions for the characterization of polymorphs and amorphous form APIs.

From Bruker BioSpin - NMR, EPR and Imaging 8 Jul 2020

KHN’s ‘What the Health?’: High court’s surprising abortion decision

The Supreme Court surprised both sides in the polarized abortion battle Monday by ruling, 5-4, that a Louisiana law requiring doctors who perform the procedure to have admitting privileges at a nearby hospital is an unconstitutional infringement of a woman's right to an abortion.

29 Jun 2020

KHN’s ‘What the Health?’: The pandemic shifts; the politics, not so much

President Donald Trump caused a stir when he said at his rally in Tulsa, Oklahoma, last weekend that he wanted less testing for COVID-19.

25 Jun 2020

KHN’s ‘What the Health?’: SCOTUS, Trump collide over transgender rights

Transgender people have had a head-spinning week. First, the Trump administration issued long-promised rules rolling back the Obama administration's protections against discrimination in health care.

18 Jun 2020

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.

16 Jun 2020

KHN’s ‘What the Health?’: Say what? The spread of coronavirus confusion

As we gain more and more information about the coronavirus and COVID-19, we seem to have less and less understanding of how the disease works and how prevalent it is in areas around the country and world.

11 Jun 2020

KHN’s ‘What the Health?’: Protests and the pandemic

Following the death of George Floyd while in custody in Minneapolis, protests have mushroomed around the U.S. to decry police violence, raising concerns among public health officials about the potential for further spread of the coronavirus.

4 Jun 2020

Bruker introduces breakthrough MALDI-2 source on timsTOF fleX, and further innovations in CCS-enabled 4D proteomics on timsTOF

At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial MALDI-2 post-ionization (PI) source, which is now available as an option on the timsTOF fleXTM ESI/MALDI mass spectrometer.

From Bruker Life Sciences Mass Spectrometry 3 Jun 2020

KHN’s ‘What the Health?’: Still seeking a federal coronavirus strategy

The Trump administration sent its COVID-19 testing strategy plan to Congress, formalizing its policy that most testing responsibilities should remain with individual states.

28 May 2020

KHN’s ‘What the Health?’: When it comes to COVID-19, states are on their own

At least so far, states that reopened their economies are not seeing a major spike in cases of COVID-19. But it remains unclear if that is because the coronavirus is not spreading, because the data is lagging or because the data is being manipulated.

21 May 2020

KHN’s ‘What the Health?’: What’s in the next round of COVID-19 relief?

House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.

14 May 2020